Arcturus Therapeutics Holdings (ARCT) Current Leases (2019 - 2026)

Arcturus Therapeutics Holdings' Current Leases history runs 8 years deep, the most recent figure standing at $4.3 million for Q1 2026.

• Quarterly Current Leases rose 17.32% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.3 million (up 17.32% YoY) and the FY2025 annual result came in at $4.2 million, up 18.64% from the prior year.
• Current Leases was $4.3 million for Q1 2026 at Arcturus Therapeutics Holdings, up from $4.2 million in the prior quarter.
• Across five years, Current Leases topped out at $4.3 million in Q4 2023 and bottomed at $1.7 million in Q1 2022.
• A 5-year average of $3.8 million and a median of $4.0 million in 2023 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2022 — Current Leases jumped 155.09% — and 2024, when it retreated 18.21%.
• Arcturus Therapeutics Holdings' Current Leases stood at $3.9 million in 2022, then rose by 10.94% to $4.3 million in 2023, then decreased by 17.57% to $3.6 million in 2024, then rose by 18.64% to $4.2 million in 2025, then increased by 2.21% to $4.3 million in 2026.
• Business Quant data shows ARCT's Current Leases at $4.3 million in Q1 2026, $4.2 million in Q4 2025, and $4.1 million in Q3 2025.